{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,6]],"date-time":"2026-01-06T05:12:00Z","timestamp":1767676320921,"version":"3.37.0"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2009,12,2]],"date-time":"2009-12-02T00:00:00Z","timestamp":1259712000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pathologe"],"published-print":{"date-parts":[[2010,2]]},"DOI":"10.1007\/s00292-009-1244-y","type":"journal-article","created":{"date-parts":[[2009,11,30]],"date-time":"2009-11-30T07:52:53Z","timestamp":1259567573000},"page":"54-59","source":"Crossref","is-referenced-by-count":3,"title":["Jenseits von Staging, Typing und Grading","Beyond staging, typing and grading"],"prefix":"10.1007","volume":"31","author":[{"given":"H.H.","family":"Kreipe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"P.","family":"Ahrens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Christgen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U.","family":"Lehmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"L\u00e4nger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2009,12,2]]},"reference":[{"key":"1244_CR1","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1093\/jnci\/djm270","volume":"100","author":"Collins","year":"2008","unstructured":"Collins LC, Marotti JD, Baer HJ, Tamimi RM (2008) Comparison of estrogen receptor results from pathology reports with results from central laboratory testing. J Natl Cancer Inst 100:218\u2013221","journal-title":"J Natl Cancer Inst"},{"key":"1244_CR2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1007\/s00428-008-0688-4","volume":"453","author":"Wasielewski","year":"2008","unstructured":"Wasielewski R, Hasselmann S, R\u00fcschoff J et al (2008) Proficiency testing of immunohistochemical biomarker assays in breast cancer. Virchows Arch 453:537\u2013543","journal-title":"Virchows Arch"},{"key":"1244_CR3","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1093\/annonc\/mdm271","volume":"18","author":"Goldhirsch","year":"2007","unstructured":"Goldhirsch A, Wood WC, Gelber RD et al (2007) Progress and promise: highlights of the international expert consensus on the primary therapy of early breast cancer 2007. Ann Oncol 18:1133\u20131144","journal-title":"Ann Oncol"},{"key":"1244_CR4","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1093\/annonc\/mdp322","volume":"20","author":"Goldhirsch","year":"2009","unstructured":"Goldhirsch A, Ingle JN, Gelber RD et al (2009) Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the primary therapy of early breast cancer 2009. Ann Oncol 20:1319\u20131329","journal-title":"Ann Oncol"},{"key":"1244_CR5","first-page":"155","volume":"11","author":"Allred","year":"1998","unstructured":"Allred DC, Harvey JM, Berardo M, Clark GM (1998) Prognostic and predictive factors in breast cancer by immunohistochemical analysis. Mod Pathol 11:155\u2013168","journal-title":"Mod Pathol"},{"key":"1244_CR6","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1126\/science.2470152","volume":"244","author":"Slamon","year":"1989","unstructured":"Slamon DJ, Godolphin W, Jones LA et al (1989) Studies of the HER-2\/neu proto-oncogene in human breast and ovarian cancer. Science 244:707\u2013712","journal-title":"Science"},{"key":"1244_CR7","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/BF03040420","volume":"116","author":"Taucher","year":"2004","unstructured":"Taucher S, Rudas M, Mader RM et al (2004) Prognostic markers in breast cancer: the reliability of HER2\/neu status in core needle biopsy of 325 patients with primary breast cancer. Wien Klin Wochenschr 116:26\u201331","journal-title":"Wien Klin Wochenschr"},{"key":"1244_CR8","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00313020701444465","volume":"39","author":"Wood","year":"2007","unstructured":"Wood B, Junckerstorff R, Sterrett G et al (2007) A comparison of immunohistochemical staining for oestrogen receptor, progesterone receptor and HER-2 in breast core biopsies and subsequent excisions. Pathology 39:391\u2013395","journal-title":"Pathology"},{"key":"1244_CR9","first-page":"259","volume":"11","author":"Jacobs","year":"1998","unstructured":"Jacobs TW, Siziopikou KP, Prioleau JE et al (1998) Do prognostic marker studies on core needle biopsy specimens of breast carcinoma accurately reflect the marker status of the tumor? Mod Pathol 11:259\u2013264","journal-title":"Mod Pathol"},{"key":"1244_CR10","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1200\/JCO.2006.09.2775","volume":"25","author":"Wolff","year":"2007","unstructured":"Wolff AC, Hammond ME, Schwartz JN et al (2007) American Society of Clinical Oncology\/College of American Pathologists guideline recommendations for human epidermal growth factor receptor 2 testing in breast cancer. J Clin Oncol 25:118\u2013145","journal-title":"J Clin Oncol"},{"key":"1244_CR11","unstructured":"Kreienberg R, Kopp I, Albert U et al (2008) Interdisziplin\u00e4re S-3 Leitlinie f\u00fcr die Diagnostik, Therapie und Nachsorge des Mammakarzinoms. Zuckschwerdt, M\u00fcnchen"},{"key":"1244_CR12","unstructured":"Kreipe H, Sinn P (2009) Pathologie. In: Thomssen C (Hrsg) Aktuelle Empfehlungen zur Therapie prim\u00e4rer und fortgeschrittener Mammakarzinome. Zuckschwerdt, M\u00fcnchen"},{"key":"1244_CR13","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.1016\/S0002-9440(10)65059-6","volume":"156","author":"Lehmann","year":"2000","unstructured":"Lehmann U, Gl\u00f6ckner S, Kleeberger W et al (2000) Detection of gene amplification in archival breast cancer specimens by laser-assisted microdissection and quantitative real-time polymerase chain reaction. Am J Pathol 156:1855\u20131864","journal-title":"Am J Pathol"},{"key":"1244_CR14","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1200\/JCO.2007.14.8197","volume":"Oncol10","author":"Sauter","year":"2009","unstructured":"Sauter G, Lee J, Bartlett JM et al (2009) Guidelines for human epidermal growth factor receptor 2 testing: biologic and methodologic considerations. J Clin Oncol10:1323\u20131333","journal-title":"J Clin"},{"key":"1244_CR15","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1038\/modpathol.3800830","volume":"20","author":"Gaedcke","year":"2007","unstructured":"Gaedcke J, Traub F, Milde S et al (2007) Predominance of the basal type and HER-2\/neu type in brain metastasis from breast cancer. Mod Pathol 20:864\u2013870","journal-title":"Mod Pathol"},{"key":"1244_CR16","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/(SICI)1096-9098(200001)73:1<17::AID-JSO5>3.0.CO;2-2","volume":"73","author":"Shimizu","year":"2000","unstructured":"Shimizu C, Fukutomi T, Tsuda H et al (2000) c-erbB-2 protein overexpression and p53 immunoreaction in primary and recurrent breast cancer tissues. J Surg Oncol 73:17\u201320","journal-title":"J Surg Oncol"},{"key":"1244_CR17","first-page":"5345","volume":"61","author":"Tanner","year":"2001","unstructured":"Tanner M, Jarvinen P, Isola J (2001) Amplification of HER-2\/neu and topoisomerase IIalpha in primary and metastatic breast cancer. Cancer Res 61:5345\u20135348","journal-title":"Cancer Res"},{"key":"1244_CR18","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1093\/annonc\/mdf252","volume":"13","author":"Gancberg","year":"2002","unstructured":"Gancberg D, Di Leo A, Cardoso F et al (2002) Comparison of HER-2 status between primary breast cancer and corresponding distant metastatic sites. Ann Oncol 13:1036\u20131043","journal-title":"Ann Oncol"},{"key":"1244_CR19","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1200\/JCO.2007.14.2364","volume":"25","author":"Harris","year":"2007","unstructured":"Harris L, Fritsche H, Mennel R et al (2007) American Society of Clinical Oncology 2007 update of recommendations for the use of tumor markers in breast cancer. J Clin Oncol 25:5287\u20135312","journal-title":"J Clin Oncol"},{"key":"1244_CR20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMoa050434","volume":"353","author":"Braun","year":"2005","unstructured":"Braun S, Vogl FD, Naume B et al (2005) A pooled analysis of bone marrow micrometastasis in breast cancer. N Engl J Med 353:793\u2013802","journal-title":"N Engl J Med"},{"key":"1244_CR21","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/nrclinonc.2009.23","volume":"6","author":"Pantel","year":"2009","unstructured":"Pantel K, Riethdorf S (2009) Pathology: are circulating tumor cells predictive of overall survival? Nat Rev Clin Oncol 6:190\u2013191","journal-title":"Nat Rev Clin Oncol"},{"key":"1244_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1159\/000123849","volume":"75","author":"Srour","year":"2008","unstructured":"Srour N, Reymond MA, Steinert R (2008) Lost in translation? A systematic database of gene expression in breast cancer. Pathobiology 75:112\u2013118","journal-title":"Pathobiology"},{"key":"1244_CR23","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(05)17878-7","volume":"365","author":"Ioannidis","year":"2005","unstructured":"Ioannidis JP (2005) Microarrays and molecular research: noise discovery? Lancet 365:454\u2013455","journal-title":"Lancet"},{"key":"1244_CR24","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMra0801289","volume":"360","author":"Sotiriou","year":"2009","unstructured":"Sotiriou C, Pusztai L (2009) Gene-expression signatures in breast cancer. N Engl J Med 360:790\u2013800","journal-title":"N Engl J Med"},{"key":"1244_CR25","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1056\/NEJMoa041588","volume":"351","author":"Paik","year":"2004","unstructured":"Paik S, Shak S, Tang G et al (2004) A multigene assay to predict recurrence of tamoxifen-treated, node-negative breast cancer. N Engl J Med 351:2817\u20132826","journal-title":"N Engl J Med"},{"key":"1244_CR26","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1038\/modpathol.2008.54","volume":"21","author":"Flanagan","year":"2008","unstructured":"Flanagan MB, Dabbs DJ, Brufsky AM et al (2008) Histopathologic variables predict Oncotype DX recurrence score. Mod Pathol 21:1255\u20131261","journal-title":"Mod Pathol"},{"key":"1244_CR27","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1038\/35021093","volume":"406","author":"Perou","year":"2000","unstructured":"Perou CM, S\u00f8rlie T, Eisen MB et al (2000) Molecular portraits of human breast tumours. Nature 406:747\u2013752","journal-title":"Nature"},{"key":"1244_CR28","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1136\/jcp.2006.041731","volume":"60","author":"Da","year":"2007","unstructured":"Da Silva L, Clarke C, Lakhani SR (2007) Demystifying basal-like breast carcinomas. J Clin Pathol 60:1328\u20131332","journal-title":"J Clin Pathol"},{"key":"1244_CR29","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/nrc2571","volume":"9","author":"Gusterson","year":"2009","unstructured":"Gusterson B (2009) Do \u201abasal-like\u2018 breast cancers really exist? Nat Rev Cancer 9:128\u2013134","journal-title":"Nat Rev Cancer"},{"key":"1244_CR30","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s00292-006-0855-9","volume":"27","author":"Wasielewski","year":"2006","unstructured":"Wasielewski R von, Kl\u00f6pper K, L\u00fcck HJ, Kreipe H (2006) Improvement of breast cancer grading in punch biopsies: grading with the Ki-67 marker. Pathologe 27:337\u2013345","journal-title":"Pathologe"},{"key":"1244_CR31","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1159\/000123848","volume":"75","author":"Ignatiadis","year":"2008","unstructured":"Ignatiadis M, Sotiriou C (2008) Understanding the molecular basis of histologic grade. Pathobiology 75:104\u2013111","journal-title":"Pathobiology"},{"key":"1244_CR32","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/annonc\/mdi352","volume":"16","author":"Colozza","year":"2005","unstructured":"Colozza M, Azambuja E, Cardoso F et al (2005) Proliferative markers as prognostic and predictive tools in early breast cancer: where are we now? Ann Oncol 16:1723\u20131739","journal-title":"Ann Oncol"},{"key":"1244_CR33","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1002\/path.1218","volume":"198","author":"Mengel","year":"2002","unstructured":"Mengel M, Wasielewski R von, Wiese B et al (2002) Inter-laboratory and inter-observer reproducibility of immunohistochemical assessment of the Ki-67 labelling index in a large multi-centre trial. J Pathol 198:292\u2013299","journal-title":"J Pathol"}],"container-title":["Der Pathologe"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1244-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00292-009-1244-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00292-009-1244-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,13]],"date-time":"2025-02-13T14:13:19Z","timestamp":1739455999000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00292-009-1244-y"}},"subtitle":["Herausforderungen und Perspektiven f\u00fcr die Tumorpathologie der Mamma","New challenges in breast cancer pathology"],"short-title":[],"issued":{"date-parts":[[2009,12,2]]},"references-count":33,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2010,2]]}},"alternative-id":["1244"],"URL":"https:\/\/doi.org\/10.1007\/s00292-009-1244-y","relation":{},"ISSN":["0172-8113","1432-1963"],"issn-type":[{"type":"print","value":"0172-8113"},{"type":"electronic","value":"1432-1963"}],"subject":[],"published":{"date-parts":[[2009,12,2]]}}}